Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional, online survey

References

• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1–9. doi: 10.1001/jama.2020.4006.
   Web of Science ®Google Scholar
• Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021;21(3):170–173. doi: 10.7861/clinmed.2021-0257.
   PubMed Web of Science ®Google Scholar
• Pinter A, van de Kerkhof P. The role of topical therapies along the psoriasis patient journey: an overview from the symposium “Tailoring topical psoriasis treatments to patients’ needs and expectations" of the 30th EADV congress 2021. J Eur Acad Dermatol Venereol. 2023;37(Suppl 1):3–8. doi: 10.1111/jdv.18761.
   PubMed Web of Science ®Google Scholar
• Menter A, Griffiths CE. Current and future management of psoriasis. Lancet. 2007;370(9583):272–284. doi: 10.1016/S0140-6736(07)61129-5.
   PubMed Web of Science ®Google Scholar
• Gupta S, Garbarini S, Nazareth T, et al. Characterizing outcomes and unmet needs among patients in the United States with mild-to-moderate plaque psoriasis using prescription topicals. Dermatol Ther (Heidelb). 2021;11(6):2057–2075. doi: 10.1007/s13555-021-00620-x.
   PubMed Web of Science ®Google Scholar
• Bewley A, van de Kerkhof P. Engaging psoriasis patients in adherence and outcomes to topical treatments: a summary from the symposium “Tailoring topical psoriasis treatments to patients’ needs and expectations" of the 30th EADV congress 2021. J Eur Acad Dermatol Venereol. 2023;37(Suppl 1):9–13. doi: 10.1111/jdv.18751.
   PubMed Web of Science ®Google Scholar
• Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176(3):759–764. doi: 10.1111/bjd.15085.
   PubMed Web of Science ®Google Scholar
• Belinchón I, Rivera R, Blanch C, et al. Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence. 2016;10:2357–2367. doi: 10.2147/PPA.S117006.
   PubMed Web of Science ®Google Scholar
• Puig L, Carrascosa JM, Belinchón I, et al. Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the psoriasis group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr. 2013;104(6):488–496.
   PubMedGoogle Scholar
• Iversen L, Dauden E, Segaert S, et al. Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients. J Eur Acad Dermatol Venereol. 2017;31(8):1271–1284. doi: 10.1111/jdv.14277.
   PubMed Web of Science ®Google Scholar
• Svendsen MT, Feldman SR, Tiedemann SN, et al. Psoriasis patient preferences for topical drugs: a systematic review. J Dermatolog Treat. 2021;32(5):478–483. doi: 10.1080/09546634.2019.1675855.
   PubMed Web of Science ®Google Scholar
• Oliveira R, Almeida IF. Patient-centric design of topical dermatological medicines. Pharmaceuticals (Basel). 2023;16(4):617. doi: 10.3390/ph16040617.
   PubMedGoogle Scholar
• Megna M, Cinelli E, Camela E, et al. Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. Expert Rev Clin Immunol. 2020;16(6):599–620. doi: 10.1080/1744666X.2020.1776116.
   PubMed Web of Science ®Google Scholar
• Torres T, Galván J, Crutchley N, et al. Calcipotriol and betamethasone dipropionate cream based on PAD technology for the treatment of plaque psoriasis: a narrative review. Dermatol Ther (Heidelb). 2023;13(10):2153–2169. doi: 10.1007/s13555-023-01003-0.
   PubMedGoogle Scholar
• García N, Guiró P, Galván J, et al. Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD technology for the treatment of plaque psoriasis on the skin and scalp. Drugs Context. 2023;12:1–8.
   Google Scholar
• Guilà T, García N, Guiró P, et al. Sensory properties analysis of the main pharmaceutical forms used in the topical treatment of plaque psoriasis. Poster 2323 presented at the 32nd European Academy of Dermatology and Venereology Congress. Berlin, 11–14 October 2023.
   Google Scholar
• Pinter A, Green LJ, Selmer J, et al. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. J Eur Acad Dermatol Venereol. 2022;36(2):228–236. doi: 10.1111/jdv.17734.
   PubMed Web of Science ®Google Scholar
• Halioua B, Caillet G, Taieb C, et al. A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: a post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis. J Eur Acad Dermatol Venereol. 2023;38(4):e326–e328. doi: 10.1111/jdv.19600.
   PubMed Web of Science ®Google Scholar
• van Cranenburgh OD, de Korte J, Sprangers MaG, et al. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013;169(2):398–405. doi: 10.1111/bjd.12372.
   PubMed Web of Science ®Google Scholar
• Bewley A, Hiribarne L, Galván J, et al. Burden of topical treatments in psoriasis and preferred criteria of choice: a survey-based evaluation of patients in Europe. Dermatol Ther (Heidelb). 2024. doi: 10.1007/s13555-024-01132-0. Online ahead of print.
   Google Scholar
• Bewley A, Page B. Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl 4):9–14. doi: 10.1111/j.1468-3083.2011.04060.x.
   PubMed Web of Science ®Google Scholar
• Praestegaard M, Steele F, Crutchley N. Polyaphron dispersion technology, a novel topical formulation and delivery system combining drug penetration, local tolerability and convenience of application. Dermatol Ther (Heidelb). 2022;12(10):2217–2231. doi: 10.1007/s13555-022-00794-y.
   PubMed Web of Science ®Google Scholar
• Curcio A, Kontzias C, Gorodokin B, et al. Patient preferences in topical psoriasis treatment. J Drugs Dermatol. 2023;22(4):326–332. doi: 10.36849/JDD.7372.
   PubMedGoogle Scholar
• Vasconcelos V, Teixeira A, Almeida V, et al. Patient preferences for attributes of topical anti-psoriatic medicines. J Dermatolog Treat. 2019;30(7):659–663.
   PubMed Web of Science ®Google Scholar
• Blome C, Simianer S, Purwins S, et al. Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology. 2010;221(2):154–159. doi: 10.1159/000313825.
   PubMed Web of Science ®Google Scholar
• Storm A, Andersen SE, Benfeldt E, et al. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59(1):27–33.
   PubMed Web of Science ®Google Scholar
• Teixeira A, Teixeira M, Almeida V, et al. Methodologies for medication adherence evaluation: focus on psoriasis topical treatment. J Dermatol Sci. 2016;82(2):63–68. doi: 10.1016/j.jdermsci.2016.02.008.
   PubMed Web of Science ®Google Scholar
• Storm A, Benfeldt E, Andersen SE, et al. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59(6):975–980. doi: 10.1016/j.jaad.2008.07.039.
   PubMed Web of Science ®Google Scholar
• Thorneloe RJ, Bundy C, Griffiths CEM, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168(1):20–31. doi: 10.1111/bjd.12039.
   PubMed Web of Science ®Google Scholar
• Barbosa CD, Balp MM, Kulich K, et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48. doi: 10.2147/PPA.S24752.
   PubMed Web of Science ®Google Scholar
• Caldarola G, De Simone C, Moretta G, et al. Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients. J Dermatolog Treat. 2017;28(8):722–725. doi: 10.1080/09546634.2017.1328100.
   PubMed Web of Science ®Google Scholar
• Eysenbach G, Wyatt J. Using the internet for surveys and health research. J Med Internet Res. 2002;4(2):E13. doi: 10.2196/jmir.4.2.e13.
   PubMed Web of Science ®Google Scholar
• Andrade C. The limitations of online surveys. Indian J Psychol Med. 2020;42(6):575–576. doi: 10.1177/0253717620957496.
   PubMedGoogle Scholar
• Shiyab W, Ferguson C, Rolls K, et al. Solutions to address low response rates in online surveys. Eur J Cardiovasc Nurs. 2023;22(4):441–444. doi: 10.1093/eurjcn/zvad030.
   PubMed Web of Science ®Google Scholar
• Egleston BL, Miller SM, Meropol NJ. The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects. Stat Med. 2011; 30(30):3560–3572. doi: 10.1002/sim.4377.
   PubMed Web of Science ®Google Scholar
• Duffy B, Smith K, Terhanian G, et al. Comparing data from online and face-to-face surveys. IJAM. 2005;47(6):615–639.
   Google Scholar
• Milton AC, Ellis LA, Davenport TA, et al. Comparison of self-reported telephone interviewing and web-based survey responses: findings from the second Australian young and well national survey. JMIR Ment Health. 2017;4(3):e37. doi: 10.2196/mental.8222.
   PubMed Web of Science ®Google Scholar